Sectors

Vishal Gupta, formerly a director at the SoftBank division that oversees its Vision Funds, has joined TA Associates in a similar role.

Q&A with Lukasz Garbowski, investment director, Btomorrow Ventures

GAC has returned to lead the Tencent and Guangzhou Public Transport-backed automated taxi developer’s latest round, which included WeRide and Pony.ai.

GS Group contributed to a series B round that pushed messenger RNA therapeutics and vaccine developer RVAC Medicines' overall funding to $140m.

HPE, Nvidia, GlobalFoundries, Intel Capital, Applied Ventures and Lockheed Martin Ventures helped push the semiconductor technology provider's total funding past $190m.

Kaloyan Andonov spoke to Anil Achyuta, investment director of TDK Ventures – the venturing arm of the Japan-based materials group TDK – about the role of advanced materials in decarbonisation, electrification, 3D printing and battery recycling

Sector report: energy Q1 2022

Global Energy Council Q2 2022 editorial by James Mawson, editor in chief, Global Corporate Venturing

Corporate-backed medical imaging technology producer Lunit is preparing to float in South Korea while cancer drug developer Pheast secured $76m from investors including Alexandria Venture Investments.

Massachusetts Mutual Life's venture capital arm has formed a fourth fund, which will concentrate on European and Asia-Pacific investments.

CVS Health joined returning backers that could include SoftBank Vision Fund 2, MassMutual Ventures, Jianke and Aviva in a round valuing the digital care service at $1.3bn.